Matches in Nanopublications for { ?s ?p "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 20 of
20
with 100 items per page.
- NP528625.RAUQo1KwtBPIdLCp7ASuaLmcr00xt-yQBvwWarN055g2Y130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528625.RAUQo1KwtBPIdLCp7ASuaLmcr00xt-yQBvwWarN055g2Y130_provenance.
- NP667666.RATK2FGkz9qx_1g34YvNSm2919LpCtl_rPP3Whlz_zWwg130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667666.RATK2FGkz9qx_1g34YvNSm2919LpCtl_rPP3Whlz_zWwg130_provenance.
- NP697139.RArEFRRmMt9cBt17X-v_5E_tOPDrj0qoGca11z5QUHb9E130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697139.RArEFRRmMt9cBt17X-v_5E_tOPDrj0qoGca11z5QUHb9E130_provenance.
- NP483338.RA7qTTvL5vGWN5I69DTIVjAsEKL7SeIaxpsZRckWCy9B4130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483338.RA7qTTvL5vGWN5I69DTIVjAsEKL7SeIaxpsZRckWCy9B4130_provenance.
- NP481222.RAbUpXvbhioUHpYuMwdVbZdhQLZRari97fril9zf4uOjo130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481222.RAbUpXvbhioUHpYuMwdVbZdhQLZRari97fril9zf4uOjo130_provenance.
- NP482485.RARQ_fz9zGJUHOvv3P-gwN68TrTeZ00XGr1ofT5hfK170130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482485.RARQ_fz9zGJUHOvv3P-gwN68TrTeZ00XGr1ofT5hfK170130_provenance.
- NP484172.RAeb-bTiD-pukitixcHITlCBu_LUkWF_ImBEXvLIdTjTc130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484172.RAeb-bTiD-pukitixcHITlCBu_LUkWF_ImBEXvLIdTjTc130_provenance.
- NP1310385.RA3g76_7INOCXe_KBSwJkY2KwDROwLWVWwzVLC7Em8MlE130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1310385.RA3g76_7INOCXe_KBSwJkY2KwDROwLWVWwzVLC7Em8MlE130_provenance.
- assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1310382.RAH50d2pMBoLgwljVVhq8Q3zRLptC2TAKRzYXwSOnMM0U130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1310382.RAH50d2pMBoLgwljVVhq8Q3zRLptC2TAKRzYXwSOnMM0U130_provenance.
- NP1310390.RALPV8tIRwut-_ZUeW7Wu_pPC8wuc3NdXCt0pRiNzLCa8130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1310390.RALPV8tIRwut-_ZUeW7Wu_pPC8wuc3NdXCt0pRiNzLCa8130_provenance.
- NP1310396.RAFVMX80uIaP5i4AFl4MHE2gttnETakPw4GbSQZyeUdJE130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1310396.RAFVMX80uIaP5i4AFl4MHE2gttnETakPw4GbSQZyeUdJE130_provenance.
- NP483921.RAtnRbxX5AtIOImL9YZcaWM3a6b3CS56kFoxOUtiKexpk130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483921.RAtnRbxX5AtIOImL9YZcaWM3a6b3CS56kFoxOUtiKexpk130_provenance.
- NP1310387.RAsqUmDZM6flI6079a20TRKE-WnHT0ArfLTXOovQcNj6E130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1310387.RAsqUmDZM6flI6079a20TRKE-WnHT0ArfLTXOovQcNj6E130_provenance.
- NP1310394.RAuKFAFWN2iOQmW9iBfacKM7kuDSLpzvcSpXsjebqVhgk130_assertion description "[IGFs (IGF-I and IGF-II) are also potent mitogens in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1310394.RAuKFAFWN2iOQmW9iBfacKM7kuDSLpzvcSpXsjebqVhgk130_provenance.